Quanome Technologies, Inc.
Quanome Technologies, Inc. is a U.S.-based integrated cross-border supply chain provider focused on freight moving between Asia and the United States, particularly China and South Korea. Its services combine ocean and air freight forwarding, consolidation, customs clearance, warehousing, distribution, and U.S. domestic ground transportation, alongside a China-based pharmaceutical distribution business operated through Hupan Pharmaceutical.
Tilikausi 2026 · muutos edellisvuodesta
Kehitys 2023–2026
Liiketoiminta
Osuus liikevaihdostaConsolidation and forwarding of Asian consumer and industrial goods into the United States.
Air cargo forwarding and related handling services for time-sensitive shipments.
Customs clearance, warehouse handling, repackaging, and distribution supporting freight movements.
Ground delivery services connecting imported freight with U.S. business and residential destinations.
Procurement, storage, and distribution of infusion fluids, specialty drugs, and medical nutrition products in China.
Tuotteet
Raportoitu · osuus liikevaihdosta- Crossborder Airfreights Solutions52,0 %
- Cross Border Ocean Freights Solutions32,5 %
- Distribution of Pharmaceutical Products15,5 %
Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.
Asiakkaat
The logistics business primarily serves Asia- and U.S.-based logistics companies that support large e-commerce platforms, social commerce platforms, and manufacturers selling Asian-made goods in the United States. These customers purchase integrated freight, customs, warehousing, and delivery services to simplify cross-border transportation and reduce supply-chain coordination requirements. The pharmaceutical business serves Chinese distributors, hospitals, clinics, and other healthcare providers, with products sourced from manufacturers and delivered through warehouses or agents. The company reported more than 400 customers and over 55,500 cross-border supply-chain orders as of June 30, 2025.
Buy outsourced freight forwarding, customs, warehousing, and delivery capacity for their end customers.
Use integrated cross-border logistics to move high volumes of Asian consumer goods into U.S. markets.
Purchase transportation and supply-chain coordination for consumer and industrial products made in Asia.
Purchase infusion fluids, prescription products, and medical nutrition products for downstream distribution.
Buy pharmaceutical and medical products for patient care and institutional use in China.
Strategia
The company is using its cross-border carrier, warehousing, and customs network to deepen integrated logistics services for Asia-to-U.S. trade flows. Its continuing operations are increasingly centered on Hupan Pharmaceutical, which distributes infusion products, specialty prescription drugs, and medical nutrition products through Chinese healthcare channels. Strategic priorities include expanding the customer base, improving service variety and technology-enabled execution, and managing the regulatory and working-capital requirements of pharmaceutical distribution. The company has also evaluated digital-asset opportunities through newly formed entities, although no such business had commenced and no concrete operating plan had been adopted in the cited report.
Customer growth supports order volumes and utilization of the integrated service network.
Combining forwarding, customs, warehousing, and delivery can improve customer retention and service value.
The segment adds a healthcare distribution channel but requires regulatory and inventory controls.
Data security, shipment coordination, and service reliability are important competitive factors in fragmented freight markets.
Maantiede
Q4/2025Quanome was founded in Chicago, Illinois, and its logistics network connects Asian origin markets with customers and delivery destinations across the United States. China and South Korea are identified as strategic Asian markets, while the company has used global freight carriers, domestic ground carriers, and regional warehousing facilities to serve U.S. shipments. Its logistics operations have delivered freight to thousands of business and residential addresses in approximately 48 U.S. states. Hupan Pharmaceutical is headquartered in Wuhan, China, and its pharmaceutical customers and distribution activity are concentrated in the Chinese market.
Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.
Riskit
Quanome operates in fragmented and highly competitive freight markets where larger providers may have greater financial resources, brand recognition, and carrier access. Its cross-border model is exposed to transportation capacity, customs rules, trade restrictions, tariffs, geopolitical conditions, and changes in carrier or supplier performance. The pharmaceutical expansion adds Chinese healthcare regulatory, product-quality, inventory, and working-capital risks, while China-centered operations create foreign-exchange exposure and customer-collection risk. The business also carries lease, loan, and convertible-note obligations that can constrain financial flexibility.
The company relies on global freight carriers and domestic ground carriers for delivery capacity and execution.
Cross-border shipments can be affected by customs modernization, quotas, trade accords, tariffs, and governmental restrictions.
Kohdistuu: Asia-to-U.S. freight flows
Medical-product handling and distribution require compliance with heightened healthcare, safety, storage, and quality requirements.
Kohdistuu: Chinese pharmaceutical operations
The company purchases products, holds them in designated warehouses, and may face cash strain before customer collection.
Kohdistuu: Pharmaceutical product inventory
Freight forwarding is fragmented, and competitors may have greater scale, technology investment, or customer recognition.
Kohdistuu: Cross-border logistics services
China operations are reported in U.S. dollars while customers may pay in Renminbi and main customer terms extend 60-90 days.
Kohdistuu: Renminbi and customer receivables
Kirjanpito
Harkinnanvaraiset erätWarrants are assessed under ASC 480 and ASC 815 as equity- or liability-classified instruments.
Vaikutus: Liability classification can create fair-value changes through reported earnings.
The company purchases products from manufacturers and delivers them to distributors, hospitals, clinics, or other specified locations.
Vaikutus: Delivery terms, rebates, discounts, and principal-versus-agent judgments affect revenue timing and amount.
Pharmaceutical operations hold products in designated warehouses before customer delivery.
Vaikutus: Inventory valuation, product costs, and potential obsolescence affect gross profit and working capital.
The company operates primarily in China but reports in U.S. dollars.
Vaikutus: Renminbi movements can change reported revenue, assets, liabilities, and profitability.
Main customer payment terms are generally 60-90 days, while supplier terms are approximately 60 days.
Vaikutus: Credit losses or delayed collection can reduce operating cash flow and require allowances.
Warehouse and office leases and the Hupan acquisition create recurring lease and amortization considerations.
Vaikutus: Lease measurement, depreciation, amortization, and impairment estimates affect assets and operating expenses.
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Cellyan Biotechnology Co., Ltd
HKPD · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cellyan Biotechnology Co., Ltd is a Cayman Islands holding company with operating subsidiaries in Hong Kong that serve the OTC pharmaceutical cross-border trade market.
ICZOOM Group Inc.
IZM · Retail-Radio, Tv & Consumer Electronics Stores
Quantum Corporation
QMCO · Computer Storage Devices
Quantum Corp is a U.S.-based storage technology company that designs, manufactures, and sells primary storage, secondary storage, and data management solutions.
QUALCOMM Incorporated
QCOM · Radio & Tv Broadcasting & Communications Equipment
QUALCOMM Inc.
Quantum X Inc.
QUTX · Services-Business Services, NEC
Tian'an Technology Group Ltd
TANAF · Motors & Generators
Tian'an Technology Group Ltd is a holding company whose operating activities are carried out through subsidiaries in Hong Kong and mainland China.
Päivitetty: 24.9.2026